NCT02861105View on ClinicalTrials.gov

The Effect of LMWH on ICSI in Patients With Unexplained Infertility and Negative Immunological Markers

PHASE4CompletedINTERVENTIONAL
Enrollment

716

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

March 31, 2016

Conditions
Unexplained Infertility
Interventions
DRUG

LMWH

LMWH will be given on daily basis subcutaneously every 24 hours starting one day after ovum pick up till documentation of fetal life by ultrasound at 7 weeks.

OTHER

0.9% saline solution

0.9% saline solution will be given subcutaneously every 24 hours starting one day after ovum pick up till documentation of fetal life by ultrasound at 7 weeks.

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT02861105 - The Effect of LMWH on ICSI in Patients With Unexplained Infertility and Negative Immunological Markers | Biotech Hunter | Biotech Hunter